The T1796A mutation of the BRAF gene is absent in Spitz nevi

Journal of Cutaneous Pathology

Volumn 31, Issue 3, 2004, Pages 266-270

  Palmedo, Gabriele ^a   Hantschke, Markus ^a   Rütten, Arno ^a   Mentzel, Thomas ^a   Hügel, Heino ^a   Flaig, Michael J ^b   Yazdi, Amir S ^b   Sander, Christian A ^b   Kutzner, Heinz ^a  

^a Dermatopathologische Gemeinschaftspraxis   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SERINE THREONINE KINASE;

ARTICLE; CELL PROLIFERATION; CONGENITAL NEVUS; CONTROLLED STUDY; DYSPLASTIC NEVUS; GENE MUTATION; HUMAN; HUMAN TISSUE; JUVENILE MELANOMA;

BASE SEQUENCE; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; HUMANS; MELANOMA; MITOGEN-ACTIVATED PROTEIN KINASES; NEVUS, EPITHELIOID AND SPINDLE CELL; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RAF; RAS PROTEINS; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 1242315442     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0303-6987.2003.00179.x     Document Type: Article

References (9)

1. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949.
2. Pollock PM, Harper UL, Hansen KS, et al. High frequency of BRAF muations in nevi. Nat Genet 2003; 33: 19.
3. Yazdi AS, Palmedo G, Flaig MJ, et al. Mutations of the BRAF gene in benign and malignant melanocytic lesions. J Invest Dermatol 2003; 121: 1160.
4. Herlyn M, Salyamoorthy K. Activated ras: yet another player in melanoma? Am J Pathol 1996; 149: 739.
5. Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol 2000; 157: 967.
6. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57.
7. Weinberg RA. Oncogenes, antioncogenes and the molecular bases of multistep carcinogenesis. Cancer Res 1989; 49: 3713.
8. Campisi J. Cancer, aging and cellular senescence. In Vivo 2000; 14: 183.
9. Sviderskaya EV, Gray-Schopfer VC, Hill SP et al. P16/cyclin-dependant kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis and immortalization: possible implications for melanoma progression. JNCI 2003; 95: 723.